{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:12:51Z","timestamp":1749010371323,"version":"3.41.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Thiamylal exerts excellent sedative effects. However, it is not routinely used because of its serious adverse effects. This study aimed to clarify the target blood concentration range and infusion rate of thiamylal in children by measuring its blood concentration and evaluating its relationship with efficacy and adverse effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study was approved by the Ethics Committee of Japanese Red Cross Kumamoto Hospital. The authors included 10 children aged between 1 and 7 years who had received continuous intravenous (IV) infusion of thiamylal for the management of refractory status epilepticus, excluding those who met the exclusion criteria. After a 2 mg\/kg bolus injection of thiamylal, continuous IV infusion was initiated at a rate of 2\u20133 mg\/kg\/h. Thiamylal concentration in the blood was measured using high-performance liquid chromatography. The State Behavioral Scale and the frequency of bolus injections were used to evaluate efficacy. Blood pressure and heart rate were measured to evaluate adverse effects. Statistical analyses of the time to awakening and the factors affecting it were also conducted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The State Behavioral Scale score during thiamylal administration was \u22122 or lower in all cases, suggesting that the depth of sedation was sufficient. The frequency of bolus injections decreased in a blood concentration-dependent manner, suggesting that the frequency tended to decrease, especially at thiamylal blood concentrations of 20 mcg\/mL or higher. An increase of the infusion rate to 3 mg\/kg\/h was recommended, because the blood concentration may not reach 20 mcg\/mL at an infusion rate of 2 mg\/kg\/h. There was also a case in which a rapid increase in blood concentration accompanied by a decrease in blood pressure and heart rate was observed when the infusion rate was increased to 4 mg\/kg\/h. Furthermore, the time to awakening after the end of administration correlated with the highest blood concentration during administration; therefore, delayed awakening was noted when using a high dose of thiamylal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The target blood concentration of thiamylal in children should be 20\u201330 mcg\/mL, and the infusion rate should be based on 3 mg\/kg\/h.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001153","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T13:06:39Z","timestamp":1701263199000},"page":"397-403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation for Blood Concentration and Efficacy\/Safety of Continuous Administration of Thiamylal in Children"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8963-2228","authenticated-orcid":false,"given":"Kenshiro","family":"Hirata","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan;"},{"name":"Department of Emergency, Critical Care and Disaster Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokunori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Fujita","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Furusho","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Ishiguro","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Jingami","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Miyamura","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.braindev.2020.08.001","article-title":"Guidelines for the diagnosis and treatment of acute encephalopathy in childhood","volume":"43","author":"Mizuguchi","year":"2021","journal-title":"Brain Dev"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.braindev.2011.07.012","article-title":"Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes","volume":"34","author":"Hoshino","year":"2012","journal-title":"Brain Dev"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/jcm9082521","article-title":"The Role of secondary brain insults in status epilepticus: a systematic review","volume":"9","author":"Fontaine","year":"2020","journal-title":"J Clin Med"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ackd.2015.10.002","article-title":"The effects of CKD on cytochrome P450-mediated drug metabolism","volume":"23","author":"Ladda","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2020.03.012","article-title":"Thiamylal anaesthetic therapy for febrile refractory status epilepticus in children","volume":"80","author":"Ishida","year":"2020","journal-title":"Seizure"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0883073811424941","article-title":"Continuous infusion pentobarbital for refractory status epilepticus in children","volume":"27","author":"Barberio","year":"2012","journal-title":"J Child Neurol"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0887-8994(01)00311-3","article-title":"Neurologic outcomes of pediatric epileptic patients with pentobarbital coma","volume":"25","author":"Kim","year":"2001","journal-title":"Pediatr Neurol"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0972-5229.156476","article-title":"Complications during the management of pediatric refractory status epilepticus with benzodiazepine and pentobarbital infusions","volume":"19","author":"Patten","year":"2015","journal-title":"Indian J Crit Care Med"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.wnl.0000173066.89001.f9","article-title":"Propofol and thiopental for refractory status epilepticus in children","volume":"65","author":"van Gestel","year":"2005","journal-title":"Neurology"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0379-0738(97)00155-2","article-title":"Distribution of drugs in various tissues in a brain dead man","volume":"90","author":"Jitsufuchi","year":"1997","journal-title":"Forensic Sci Int"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3999\/jscpt.17.13","article-title":"[Pharmacokinetics and electroencephalogram of thiamylal] Thiamylal no tainaidoutai to nouha","volume":"17","author":"Norifumi","year":"1986","journal-title":"Jpnapanese J Clin Pharmacology Ther"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.PCC.0000200955.40962.38","article-title":"State Behavioral Scale: a sedation assessment instrument for infants and young children supported on mechanical ventilation","volume":"7","author":"Curley","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"R14-20250603","first-page":"54","article-title":"The Period of time indicator for prevention of pediatric patients from falling after the use of hypnotics, sedatives, and anestheties: a survey of the judgment of nurses applying the Delphi technique","volume":"22","author":"Yuichi","year":"2013","journal-title":"J Jpn Soc Child Health Nurs"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3747\/pdi.2015.00044","article-title":"Peritoneal dialysis in infants: never lose sight of\u2014and from\u2014arterial hypotension","volume":"35","author":"Schaefer","year":"2015","journal-title":"Perit Dial Int"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.PCC.0000257039.32593.DC","article-title":"Analysis of the evidence for the lower limit of systolic and mean arterial pressure in children","volume":"8","author":"Haque","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00128072-200204070-00003","article-title":"Controlled hypotension in children: a critical review of available agents","volume":"4","author":"Tobias","year":"2002","journal-title":"Paediatr Drugs"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:11:37Z","timestamp":1748970697000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001153","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"2023-05-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}